Treatment of high-risk, non-muscle-invasive bladder cancer

Nature Clinical Practice Urology

Volumn 3, Issue 8, 2006, Pages 398-399

  Lerner, Seth P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; BIOLOGICAL MARKER; GEMCITABINE; MITOMYCIN C; PROTEIN P53;

BLADDER CANCER; BLADDER MUCOSA; CANCER GRADING; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; CYSTECTOMY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GENE EXPRESSION; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; MAINTENANCE THERAPY; PRIORITY JOURNAL; REVIEW; TRANSITIONAL CELL CARCINOMA; TREATMENT PLANNING;

ADJUVANTS, IMMUNOLOGIC; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE PROGRESSION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 33747182476     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro0517     Document Type: Review

References (10)

1. Oosterlinck W et al. (2002) Guidelines on bladder cancer. Eur Urol 41:105-112
2. Millan-Rodriguez F et al. (2000) Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163: 73-78
3. Herr HW (1998) Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol 16: 1099-1102
4. Lamm DL et al. (2000) Maintenance bacillus Calmette-Guérin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study. J Urol 163: 1124-1129
5. Lerner SP (2005) Bladder cancer clinical trials. Urol Oncol 23: 275-279
6. Dinney CP et al. (1998) Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. J Urol 160: 1285-1290
7. O'Donnell MA et al. (2004) Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer. J Urol 172: 888-893
8. Dalbagni G et al. (2002) Phase I trial of intravesical gemcitabine in bacillus Calmette - Guérin-refractory transitional-cell carcinoma of the bladder. J Clin Oncol 20: 3193-3198
9. Bartoletti R et al. (2005) Intravesical gemcitabine therapy for superficial transitional cell carcinoma: Results of a phase II prospective multicenter study. Urology 66: 726-731
10. van der Heijden AG et al. (2004) Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur Urol 46: 65-71